BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2411137)

  • 61. CA 125 and TPA as markers in ovarian carcinoma.
    Rodenburg CJ; De Maaker GA; Trimbos JB; Moolenaar AJ; Van Oosterom AT
    Neth J Med; 1985; 28(12):536-40. PubMed ID: 2418375
    [No Abstract]   [Full Text] [Related]  

  • 62. A study of the Ca antigen in epithelial tumours of the ovary.
    Ferguson AM; Fox H
    J Clin Pathol; 1984 Jan; 37(1):6-9. PubMed ID: 6368598
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Serum levels of CA-125 in patients with endometriosis: a preliminary report.
    Giudice LC; Jacobs A; Pineda J; Bell CE; Lippmann L
    Fertil Steril; 1986 Jun; 45(6):876-8. PubMed ID: 3458595
    [TBL] [Abstract][Full Text] [Related]  

  • 64. CA-125 monitoring during chemotherapy for ovarian cancer.
    Martoni A; Bellucco A; Marabini A; Orlandi C; Platé L; Bianchi D; Pannuti F
    Int J Biol Markers; 1986; 1(3):121-8. PubMed ID: 3480916
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Serum CA 125 levels in preoperative evaluation of pelvic masses.
    Vasilev SA; Schlaerth JB; Campeau J; Morrow CP
    Obstet Gynecol; 1988 May; 71(5):751-6. PubMed ID: 3162763
    [TBL] [Abstract][Full Text] [Related]  

  • 66. CA 125 and survival in ovarian cancer: preliminary communication.
    Parker D; Patel K; Alred EJ; Harnden-Mayor P; Naylor B
    J R Soc Med; 1988 Jan; 81(1):22. PubMed ID: 3422695
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical use of CA 125 and its combination assay with other tumor marker in patients with ovarian carcinoma.
    Negishi Y; Furukawa T; Oka T; Sakamoto M; Hirata T; Okabe K; Matayoshi K; Akiya K; Soma H
    Gynecol Obstet Invest; 1987; 23(3):200-7. PubMed ID: 3474196
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Identification of two different surface epitopes of human ovarian epithelial carcinomas by monoclonal antibodies.
    Tsuji Y; Suzuki T; Nishiura H; Takemura T; Isojima S
    Cancer Res; 1985 May; 45(5):2358-62. PubMed ID: 2580620
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Expression of monoclonal antibody-defined tumor markers in four carcinomas.
    Wu JT
    Ann Clin Lab Sci; 1989; 19(1):17-26. PubMed ID: 2916833
    [TBL] [Abstract][Full Text] [Related]  

  • 70. CA 15-3 serum levels in ovarian cancer.
    Scambia G; Benedetti Panici P; Baiocchi G; Perrone L; Greggi S; Di Roberto P; Mancuso S
    Oncology; 1988; 45(3):263-7. PubMed ID: 3163419
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical evaluation of circulating serum sialyl Tn antigen levels in patients with epithelial ovarian cancer.
    Kobayashi H; Terao T; Kawashima Y
    J Clin Oncol; 1991 Jun; 9(6):983-7. PubMed ID: 1851822
    [TBL] [Abstract][Full Text] [Related]  

  • 72. CA 125 for the monitoring of ovarian carcinoma during primary therapy.
    Lavin PT; Knapp RC; Malkasian G; Whitney CW; Berek JC; Bast RC
    Obstet Gynecol; 1987 Feb; 69(2):223-7. PubMed ID: 2433652
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Serum CA-125 antigen levels increase during menses.
    Pittaway DE; Fayez JA
    Am J Obstet Gynecol; 1987 Jan; 156(1):75-6. PubMed ID: 3467595
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Characterization of an epithelial and a tumor-associated human small cell lung carcinoma glycoprotein antigen.
    Waibel R; O'Hara CJ; Stahel RA
    Cancer Res; 1987 Jul; 47(14):3766-70. PubMed ID: 2439198
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Serological mapping of the TAG-72 tumor-associated antigen using 19 distinct monoclonal antibodies.
    Kuroki M; Fernsten PD; Wunderlich D; Colcher D; Simpson JF; Poole DJ; Schlom J
    Cancer Res; 1990 Aug; 50(16):4872-9. PubMed ID: 1696162
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical significance of cancer antigen 125 (CA 125) in ovarian cancer.
    Crombach G; Zippel HH; Würz H
    Cancer Detect Prev; 1985; 8(1-2):135-9. PubMed ID: 3864535
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Selection of a monoclonal antibody reactive with a high-molecular-weight glycoprotein circulating in the body fluid of gastrointestinal cancer patients.
    Sakurai Y; Hirohashi S; Shimosato Y; Kodaira S; Abe O
    Cancer Res; 1988 Jul; 48(14):4053-8. PubMed ID: 2454734
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [A radioimmunometric assay for circulating tumor-associated glycoprotein (TAG-72) using the antigen determinant CA 72-4].
    Ohuchi N; Takahashi K; Matoba N; Mori S
    Gan To Kagaku Ryoho; 1988 Sep; 15(9):2761-6. PubMed ID: 2458074
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Recognition of ovarian cancer antigen CA125 by murine monoclonal antibody produced by immunization of lung cancer cells.
    Matsuoka Y; Nakashima T; Endo K; Yoshida T; Kunimatsu M; Sakahara H; Koizumi M; Nakagawa T; Yamaguchi N; Torizuka K
    Cancer Res; 1987 Dec; 47(23):6335-40. PubMed ID: 3315184
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Elevated levels of a high molecular weight antigen detected by antibody W1 in sera from breast cancer patients.
    Linsley PS; Ochs V; Laska S; Horn D; Ring DB; Frankel AE; Brown JP
    Cancer Res; 1986 Oct; 46(10):5444-50. PubMed ID: 2428478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.